APUS APIMEDS PHARMACEUTICALS US I
FollowCOM SHS (common), issuer CIK 1894525
5 managers (6 13F filers) reported a position in APUS shares at 2026-03-31, 448,756 shares in all. 1 filer opened a position and 3 filers sold out during the quarter.
- Managers
- 5
- 13F filers
- 6
- New
- 1
- Added
- 2
- Reduced
- 0
- Sold out
- 3
- Shares held by filers
- 448,756
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2026
Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Hemenway Trust Co LLC | 274,000 | $490K | 0.04% | 0 | 13F-HRTimeline |
| VANGUARD GROUP INCgroup of 2 filers holding | 119,968 | $215K | new | Timeline
| |
| GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC | 40,051 | $71.7K | <0.01% | +5,163 | 13F-HRTimelineGroup |
| TWO SIGMA SECURITIES, LLC | 10,550 | $18.9K | <0.01% | new | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 4,187 | $7.49K | <0.01% | +3,605 | 13F-HRTimelineGroup |